In a paper published in June in the Journal of the American Chemical Society, the research team described how they developed a way to attach SARS-CoV-2 antibodies to sugar and then have the glucose reader measure those sugar levels, which reflect the antibody levels.
... despite a growing supply of the Jynneos vaccine -- and a new strategy that could stretch the current supply five times further -- there is still no evidence that protection is reaching those most at risk. ...
As new threats like monkeypox and polio re-emerge and the coronavirus continues to evolve, the potential of the old vaccine to provide a measure of universal protection against infectious diseases has gained renewed interest among scientists...
"A universal coronavirus vaccine would be a tremendous advance," says Wayne Koff, president and CEO of the Human Vaccines Project. "My expectation is that progress likely will be incremental, though there needs to be a major coordinated effort to achieve this goal."...
Recent Comments